LU87949A1 - Preparation et utilisation de porphyrines - Google Patents

Preparation et utilisation de porphyrines Download PDF

Info

Publication number
LU87949A1
LU87949A1 LU87949A LU87949A LU87949A1 LU 87949 A1 LU87949 A1 LU 87949A1 LU 87949 A LU87949 A LU 87949A LU 87949 A LU87949 A LU 87949A LU 87949 A1 LU87949 A1 LU 87949A1
Authority
LU
Luxembourg
Prior art keywords
cells
protoporphyrin
protoporphyrinogen
compound
mammals
Prior art date
Application number
LU87949A
Other languages
English (en)
French (fr)
Inventor
Halling Blaik Phillip
Witkowski Debra Ann
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of LU87949A1 publication Critical patent/LU87949A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
LU87949A 1988-12-12 1991-06-12 Preparation et utilisation de porphyrines LU87949A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US28515188A 1988-12-12 1988-12-12
US28515188 1988-12-12
US33500789A 1989-04-07 1989-04-07
US33500789 1989-04-07
US35133189A 1989-05-03 1989-05-03
US35133189 1989-05-03

Publications (1)

Publication Number Publication Date
LU87949A1 true LU87949A1 (fr) 1991-12-16

Family

ID=27403508

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87949A LU87949A1 (fr) 1988-12-12 1991-06-12 Preparation et utilisation de porphyrines

Country Status (28)

Country Link
EP (1) EP0447491B1 (el)
JP (1) JP2545000B2 (el)
KR (1) KR930003116B1 (el)
AR (1) AR243605A1 (el)
AT (1) AT400520B (el)
AU (1) AU633537B2 (el)
BR (1) BR8907817A (el)
CA (1) CA2004979A1 (el)
CH (1) CH681779A5 (el)
DE (2) DE3991484T (el)
DK (1) DK110791A (el)
EG (1) EG18822A (el)
ES (1) ES2051675T3 (el)
FI (1) FI912784A0 (el)
GB (1) GB2247404B (el)
GR (1) GR1000609B (el)
HU (1) HUT58202A (el)
IE (1) IE62621B1 (el)
IL (1) IL92622A (el)
LU (1) LU87949A1 (el)
LV (1) LV10303B (el)
MC (1) MC2171A1 (el)
NO (1) NO912228L (el)
NZ (1) NZ231658A (el)
OA (1) OA09362A (el)
PT (1) PT92546B (el)
SE (1) SE505938C2 (el)
WO (1) WO1990006748A2 (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298502A (en) * 1988-12-12 1994-03-29 Fmc Corporation Method and composition for photodynamic treatment and detection of tumors
US5132101A (en) * 1990-05-04 1992-07-21 Cytopharm, Inc. Acetylene-cumulene porphycene compounds for photodynamic therapy
US5244671A (en) * 1991-01-29 1993-09-14 Cytopharm, Inc. Derivatives of porphycene for photodynamic therapy of cancer
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
TW492975B (en) * 1993-07-26 2002-07-01 Novartis Ag Tryptase inhibitor
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
US5939602A (en) * 1995-06-06 1999-08-17 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
US5767373A (en) * 1994-06-16 1998-06-16 Novartis Finance Corporation Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
US6023012A (en) * 1996-02-28 2000-02-08 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase
US6084155A (en) * 1995-06-06 2000-07-04 Novartis Ag Herbicide-tolerant protoporphyrinogen oxidase ("protox") genes
UA70912C2 (uk) * 1996-02-28 2004-11-15 Cінгента Партісіпейшнс Аг Молекула днк, яка кодує стійку до дії інгібітора рослинну протопорфіриногеноксидазу, спосіб одержання стійких до гербіциду рослин, спосіб боротьби з ростом небажаних рослин
JPH10330359A (ja) * 1997-03-31 1998-12-15 Nippon Bayeragrochem Kk フエニルアセチレン誘導体及び除草剤
DE102005017152B4 (de) * 2005-04-13 2007-02-08 Lindauer Dornier Gmbh Verfahren zum Trocknen von vorzugsweise plattenförmigen Produkten und Durchlauftrockner in Mehretagenbauweise
SI2443102T1 (sl) 2009-06-19 2013-08-30 Basf Se Herbicidni benzoksazinoni
WO2011051393A1 (en) * 2009-11-02 2011-05-05 Basf Se Herbicidal tetrahydrophthalimides
JP2013540113A (ja) * 2010-10-01 2013-10-31 ビーエーエスエフ ソシエタス・ヨーロピア 除草性ベンゾオキサジノン
AU2011344311B2 (en) 2010-12-15 2015-05-14 Basf Se Herbicidal compositions
CN102875569A (zh) * 2012-09-27 2013-01-16 南开大学 具有除草活性和抗肝癌活性的异噁唑并嘧啶酮(或三嗪酮)类化合物
WO2018108695A1 (en) * 2016-12-16 2018-06-21 Basf Se Herbicidal phenyltriazolinones

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393071A (en) * 1975-03-17 1983-07-12 Naoharu Fujii Method of treating gastric, mammary, lung and uterus tumors
US4404019A (en) * 1980-12-24 1983-09-13 Sumitomo Chemical Company, Limited 3-Chloro-1-phenyl-1,2,4-triazolin-5-ones and their use as herbicides
CH651029A5 (de) * 1980-12-25 1985-08-30 Nihon Nohyaku Co Ltd Triazolin-derivate, verfahren zu ihrer herstellung und sie enthaltende herbizide mittel.
JPS60190711A (ja) * 1984-03-09 1985-09-28 Tokyo Tanabe Co Ltd プロトポルフイリン類注射用製剤
US4761174A (en) * 1987-04-14 1988-08-02 Fmc Corporation Triazolin-5-one herbicides
US4755217A (en) * 1987-01-15 1988-07-05 Fmc Corporation Triazinedione herbicides

Also Published As

Publication number Publication date
DK110791D0 (da) 1991-06-11
GB9110472D0 (en) 1991-11-27
CA2004979A1 (en) 1990-06-12
IL92622A0 (en) 1990-08-31
IL92622A (en) 1996-05-14
EG18822A (en) 1994-09-29
ATA903489A (de) 1995-06-15
EP0447491A1 (en) 1991-09-25
MC2171A1 (fr) 1992-05-22
GB2247404A (en) 1992-03-04
DK110791A (da) 1991-08-12
JP2545000B2 (ja) 1996-10-16
ES2051675T1 (es) 1994-07-01
NO912228D0 (no) 1991-06-11
SE505938C2 (sv) 1997-10-27
AR243605A1 (es) 1993-08-31
ES2051675T3 (es) 1994-11-01
BR8907817A (pt) 1991-10-22
CH681779A5 (el) 1993-05-28
KR910700046A (ko) 1991-03-13
GR890100817A (en) 1991-03-15
AU4822290A (en) 1990-07-10
OA09362A (en) 1992-09-15
IE62621B1 (en) 1995-02-22
PT92546A (pt) 1990-06-29
NO912228L (no) 1991-06-11
LV10303A (lv) 1994-10-20
NZ231658A (en) 1992-05-26
LV10303B (en) 1995-08-20
DE3991484T (el) 1991-11-21
FI912784A0 (fi) 1991-06-10
WO1990006748A2 (en) 1990-06-28
KR930003116B1 (ko) 1993-04-19
AT400520B (de) 1996-01-25
WO1990006748A3 (en) 1990-10-04
IE893925L (en) 1990-06-12
SE9101807D0 (sv) 1991-06-12
JPH04501420A (ja) 1992-03-12
AU633537B2 (en) 1993-02-04
SE9101807L (sv) 1991-06-12
HUT58202A (en) 1992-02-28
EP0447491B1 (en) 1993-08-11
PT92546B (pt) 1995-09-12
GB2247404B (en) 1993-03-03
GR1000609B (el) 1992-08-31
DE3991484C2 (de) 1995-02-23

Similar Documents

Publication Publication Date Title
LU87949A1 (fr) Preparation et utilisation de porphyrines
US5407808A (en) Method and composition for photodynamic treatment and detection of tumors
US5298502A (en) Method and composition for photodynamic treatment and detection of tumors
EP2726087B1 (fr) Compositions pour le traitement ou la prévention du cancer de la prostate à base d'extrait de graines de brocoli
EP0352146A1 (fr) Régulateur biologique extrait de Gingko Biloba, actif dans diverses pathologies.
CS176291A3 (en) Pharmaceutical
RU2074719C1 (ru) Способ разрушения опухолевых клеток млекопитающих и фармацевтическая композиция для разрушения опухолевых клеток млекопитающих
JPH06504278A (ja) ヒトの高い血糖値を低下させる方法
LT3997B (en) Process for preparing protoporphyrins and use thereof
EP3515210B1 (en) Materials and methods for producing and using mitochondrial preparations
JP3308497B2 (ja) コーヒー豆から抽出されたｓｏｄ様抽出組成物
WO1991013892A1 (fr) Nouveau derive organique d'un metal a structure phospholipidique, utilisation de ce derive comme agent biomediateur, procede d'isolement de ce derive et compositions pharmaceutiques le contenant
FR2600892A1 (fr) Utilisation du fructose-1,6-diphosphate pour la preparation d'une composition pharmaceutique pour la protection contre la toxicite induite par l'administration d'anthracyclines et compositions correspondantes
HRP930762A2 (en) Preparation and use of porphyrin
FR2649889A1 (fr) Agent contenant un compose organique du germanium pour la prevention et le traitement de l'opacite du cristallin
WO1995016457A1 (fr) Aspartame pour son application en tant que substance therapeutiquement active
FR2654620A1 (fr) Nouveaux derives organiques de metal de transition a structure porphyrinique et composition therapeutique le contenant, en particulier activite hypoglycemiante.
FR2805164A1 (fr) Medicaments contre l'atherosclerose a base de composes derives de chromone
JPH06172166A (ja) 白内障治療剤
BE881094A (fr) Inducteur d'interferon utile comme medicament et procede pour sa preparation